Tsumura & Co.
$23.20+0.00%(+$0.00)
TickerSpark Score
66/100
96
Valuation
85
Profitability
35
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSMRF research report →
52-Week Range0% of range
Low $23.20
Current $23.20
High $28.15
Companywww.tsumura.co.jp
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations.
- CEO
- Terukazu Kato
- IPO
- 2013
- Employees
- 4,138
- HQ
- Tokyo, JP
Price Chart
-17.58% · this period
Valuation
- Market Cap
- $1.73B
- P/E
- 10.32
- P/S
- 1.51
- P/B
- 0.90
- EV/EBITDA
- 6.41
- Div Yield
- 3.77%
Profitability
- Gross Margin
- 47.51%
- Op Margin
- 18.29%
- Net Margin
- 14.60%
- ROE
- 9.29%
- ROIC
- 4.97%
Growth & Income
- Revenue
- $193.83B · 7.03%
- Net Income
- $28.29B · -12.75%
- EPS
- $378.68 · -11.35%
- Op Income
- $35.44B
- FCF YoY
- -301.36%
Performance & Tape
- 52W High
- $28.15
- 52W Low
- $23.20
- 50D MA
- $23.20
- 200D MA
- $23.23
- Beta
- 0.04
- Avg Volume
- 50.4
Get TickerSpark's AI analysis on TSMRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TSMRF Coverage
We haven't published any research on TSMRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TSMRF Report →Similar Companies
HTSUF+0.00%
Hisamitsu Pharmaceutical Co., Inc.
$29.00
DMPHF+0.00%
Dermapharm Holding SE
$39.56
CHSYF+0.00%
China Medical System Holdings Limited
$1.35
SHPHF+0.00%
Sihuan Pharmaceutical Holdings Group Ltd.
$0.19
CURLF+3.42%
Curaleaf Holdings, Inc.
$3.33
LBTSF-0.78%
Almirall, S.A.
$15.35
ARSUF+0.00%
Fagron N.V.
$26.53
CASBF+0.00%
CanSino Biologics Inc.
$3.89